AI in Life Sciences: From Discovery to Impact
Come join us on October 14 from 3 to 9pm for AI in Life Sciences: From Discovery to Impact!
This exclusive, invite-only event will bring together academia, biotech, pharma, healthcare, investment, and innovation organizations for an evening of industry insights, frontier research discoveries, and community networking focused on how AI is transforming drug discovery, biomanufacturing, and healthcare.
Hosted by ACERCA Quebec, with support from the Embassy of Spain, Spanish and Catalonia Trade & Investment, McGill University, and Mila Ventures.
Program
15:00 – 15:30 | Registration & Welcome Coffee
15:30 – 15:35 | Institutional Opening with the Spanish Embassy
15:35 – 15:40 | Introduction of the Canadian Spanish Scientists Association (ACERCA)
15:40 – 16:25 | The Importance of AI in the Pharmaceutical Industry
Moderator: Tania Ramos Moreno - Strominnate Therapeutics & Innatera Therapeutics Inc
Rana Shihabeldeen. Merck
Genevieve Larouche. Knight Therapeutics
Pedro Vaccara. GSK
Walter Tejada. Medison Pharma
16:25 – 17:10 | From drug discovery to clinical trials
Moderator: Esther del Cid Pellitero. Innatera Therapeutics Inc
Michael Mahdavi. Insilico Medicine
Andrea Dumont. ICON Strategic Solutions, on assignment with Bayer
17:10 – 17:30 | Coffee Break
17:30 – 17:40 | AI Models in Mental Health.
Luis Seco Sapientem Life
17:40 – 17:50 | AI for scaling-up the manufacturing process
Stefano Melchior. BeChained
17:50 – 18:35 | Protecting and Scaling Bio-Assets
Moderator: Fernando Ortiz. Ottawa Hospital Research Institute
Julien Verneau. Fasken
Tania Ramos Moreno. Strominnate Therapeutics & Innatera Therapeutics Inc
Assya Trofimov. Cognate Labs
Jordan Dekraker. BrainScores
18:35 – 18:50 | The Social Implications of AI in Healthcare
Lourdes Rodríguez del Barrio. Center InterActions & Université de Montréal
18:50 – 19:00 | Closure
19:00 – 21:00 | Networking